TEVAOXALI 5 MG/ML SOL INJ CT FA VD TRANS X 40 ML

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1557300050063
  • GGREM 537501005154413
  • Código de barras 7898919603084

O que a fonte publica

Detentor do registro
TEVA FARMACÊUTICA LTDA.
Princípios ativos
OXALIPLATINA
Embalagem
5 MG/ML SOL INJ CT FA VD TRANS X 40 ML
Tipo de produto
Similar
Classe terapêutica
L1F - COMPOSTOS ANTINEOPLÁSICOS DE PLATINA

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:537501005154413
{
  "name": "TEVAOXALI 5 MG/ML SOL INJ CT FA VD TRANS X 40 ML",
  "holder": "TEVA FARMACÊUTICA LTDA.",
  "stripe": null,
  "barcodes": [
    "7898919603084"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "537501005154413",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "05.333.542/0001-08",
  "priceRegime": "Regulado",
  "productName": "TEVAOXALI",
  "productType": "Similar",
  "hospitalOnly": true,
  "presentation": "5 MG/ML SOL INJ CT FA VD TRANS X 40 ML",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "11067.89",
    "icms-12": "12577.15",
    "icms-17": "13334.80",
    "icms-18": "13497.42",
    "icms-19": "13664.06",
    "icms-20": "13834.86",
    "icms-21": "14009.99",
    "icms-22": "14189.60",
    "icms-23": "14373.88",
    "icms-17.5": "13415.62",
    "icms-19.5": "13748.93",
    "icms-20.5": "13921.88",
    "icms-22.5": "14281.15",
    "icms-12-alc": "12426.22",
    "icms-17-alc": "13174.78",
    "icms-18-alc": "13335.46",
    "icms-19-alc": "13500.09",
    "icms-20-alc": "13668.83",
    "icms-21-alc": "13841.87",
    "icms-22-alc": "14019.32",
    "icms-23-alc": "14201.39",
    "withoutTaxes": "10935.08",
    "icms-17.5-alc": "13254.63",
    "icms-19.5-alc": "13583.94",
    "icms-20.5-alc": "13754.81",
    "icms-22.5-alc": "14109.78"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "OXALIPLATINA",
  "targetSpecies": [],
  "consumerPrices": null,
  "invalidBarcodes": [],
  "activeSubstances": [
    "OXALIPLATINA"
  ],
  "therapeuticClass": "L1F - COMPOSTOS ANTINEOPLÁSICOS DE PLATINA",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1557300050063",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "L1F",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:537501005154413"